相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation
Rachelle W. Johnson et al.
BONE (2014)
UThe Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation
Rachelle W. Johnson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH
Vaibhav Saini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone
Farzin M. Takyar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Preosteocytes/Osteocytes Have the Potential to Dedifferentiate Becoming a Source of Osteoblasts
Elena Torreggiani et al.
PLOS ONE (2013)
Sustained RANKL Response to Parathyroid Hormone in Oncostatin M Receptor-Deficient Osteoblasts Converts Anabolic Treatment to a Catabolic Effect In Vivo
Emma C. Walker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts
Sang Wan Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice
Gang-Qing Yao et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Matrix-embedded cells control osteoclast formation
Jinhu Xiong et al.
NATURE MEDICINE (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
GP130 cytokines and bone remodelling in health and disease
Natalie A. Sims et al.
BMB REPORTS (2010)
Identification of cells at early and late stages of polarization during odontoblast differentiation using pOBCol3.6GFP and pOBCo12.3GFP transgenic mice
Anamaria Balic et al.
BONE (2010)
Ciliary Neurotrophic Factor Inhibits Bone Formation and Plays a Sex-Specific Role in Bone Growth and Remodeling
Narelle E. McGregor et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
Jun Guo et al.
CELL METABOLISM (2010)
Parathyroid Hormone (PTH)-Induced Bone Gain Is Blunted in SOST Overexpressing and Deficient Mice
Ina Kramer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
Emma C. Walker et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
Emma C. Walker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts
Elizabeth H. Allan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Building bone to reverse osteoporosis and repair fractures
Sundeep Khosla et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
Robert Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
DMP1-targeted Cre expression in odontoblasts and osteocytes
Y. Lu et al.
JOURNAL OF DENTAL RESEARCH (2007)
TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
JC Dai et al.
BONE (2006)
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling
NA Sims et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34
DS Miao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effects of parathyroid hormone on Wnt signaling pathway in bone
NH Kulkarni et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use
AB Hodsman et al.
ENDOCRINE REVIEWS (2005)
Differentiation potential of a mouse bone marrow stromal cell line
EH Allan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
P Palmqvist et al.
JOURNAL OF IMMUNOLOGY (2002)
Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation
YFL Ma et al.
ENDOCRINOLOGY (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: Synergy with dexamethasone
CD Richards et al.
CYTOKINE (2000)
分享论文
